share_log

NEXGEL, Inc. (NASDAQ:NXGL) Short Interest Update

kopsource ·  Dec 30, 2022 01:01

NEXGEL, Inc. (NASDAQ:NXGL – Get Rating) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 50,700 shares, a growth of 218.9% from the November 30th total of 15,900 shares. Based on an average daily volume of 41,400 shares, the days-to-cover ratio is presently 1.2 days. Currently, 1.2% of the company's shares are short sold.

NEXGEL Stock Up 4.8 %

Shares of NASDAQ:NXGL traded up $0.06 during midday trading on Thursday, reaching $1.29. The company's stock had a trading volume of 36,736 shares, compared to its average volume of 125,468. The company has a quick ratio of 7.10, a current ratio of 7.46 and a debt-to-equity ratio of 0.03. The firm has a 50 day moving average price of $1.35 and a two-hundred day moving average price of $1.57. NEXGEL has a fifty-two week low of $1.09 and a fifty-two week high of $3.62.

Get NEXGEL alerts:

NEXGEL (NASDAQ:NXGL – Get Rating) last posted its quarterly earnings results on Tuesday, November 8th. The company reported ($0.22) earnings per share for the quarter. NEXGEL had a negative return on equity of 57.42% and a negative net margin of 278.85%. The firm had revenue of $0.57 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NEXGEL stock. Renaissance Technologies LLC purchased a new position in shares of NEXGEL, Inc. (NASDAQ:NXGL – Get Rating) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 20,231 shares of the company's stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.36% of NEXGEL as of its most recent filing with the SEC. 1.91% of the stock is owned by institutional investors.

About NEXGEL

(Get Rating)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Featured Stories

  • Get a free copy of the StockNews.com research report on NEXGEL (NXGL)
  • 3 High-Yield Dividend Stocks to Hold for the Long Haul
  • Cal-Maine Posts Record Quarter, Remain CALM Income Investors
  • Tesla Stock: What the Bulls and the Bears Are Getting Wrong
  • Big Health Care Stocks to Watch in the New Year
  • The Top Three Stocks Analysts Say To Buy

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment